The Immune Tolerance Network (ITN) has announced a new clinical research fellowship program that will provide promising junior-level faculty with intensive, hands-on training in the planning, design ...

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the participation of its CEO David W.

Accord Healthcare (Accord), one of Europe's fastest growing pharmaceutical companies, marks World Cancer Day 2023 today by taking part in news-style programme for ITN Business alongside other partners ...